Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AlphaVax Inc.

www.alphavax.com

Latest From AlphaVax Inc.

Ebola – The industry's response in vaccines

The latest Ebola epidemic, which the WHO says has now claimed more than 9,600 lives, has focused attention on the long-term need for a prophylactic vaccine to prevent future outbreaks of this size.

Gastrointestinal Gynecology & Urology

Novartis acquires vaccine programme from AlphaVax

Novartishas acquired an investigational cytomegalovirus (CMV) vaccine programme from the US-based vaccine developer AlphaVax for $20 million.

Infectious Diseases Companies

Prostate Cancer Market: $2 Billion and Growing

Although prostate problems have plagued men for many years, the growing elderly population is now driving an unprecedented increase in caseloads and a corresponding need for improved treatments. One of the primary concerns is the rise in prostate cancer diagnoses. With more than two million American men currently living with prostate cancer and more than 200,000 new cases diagnosed each year, the market for diagnostic and therapeutic products to address this disease is substantial; more than $2 billion in the US in 2007.
Medical Device

AlphaVax Inc.

Alphavax is developing a vaccine vector using a genetically modified Venezuelan equine encephalitis (VEE) virus. Therapeutic areas of focus include HIV, other infectious diseases and tumor immunotherapy.
BioPharmaceutical Business Strategies
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Vaccines
  • Therapeutic Areas
  • Cancer
  • Infectious & Viral Diseases
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • AlphaVax Inc.
  • Senior Management
  • Tim C Gupton, CFO
    Janice A Kimpel , PhD, VP, Bus. Dev.
    Jonathan Smith, CSO
  • Contact Info
  • AlphaVax Inc.
    Phone: (919) 595-0400
    2 Triangle Dr.
    P.O. Box 110307 Research Triangle Park, NC 27709-0307
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register